The MiSight 1 day clinical trial is the longest-running soft contact lens study among children, and is now reporting seven-year data. With questions explored including efficacy, cross over from control group to treatment and discontinuation, here’s some of what we’ve learnt along the way.
In this Q&A Interview, Optometrist Elizabeth Lumb reflects on the evolution of myopia management in the past five years through two ‘lenses’: as CooperVision’s Director of Global Professional Affairs, Myopia Management, and through the very personal experience of her now 12-year-old niece, Maddy.
In this case, we meet a child whose axial length has progressed 0.4mm in one year, even with myopia control treatment. Yet, his refractive error hasn’t changed. What could cause this and what is the best course of action?
This paper identified time spent outdoors as the key factor in predicting better myopia control outcomes in children wearing with MiSight 1 day contact lenses. Other factors which weren’t predictive included age, refraction, binocular vision findings, pupil size and time spent at near.
This case is highlights that myopia management decision making includes much more than a child’s refraction. Learn how Keyur Patel involved the parent in the conversation and decision making, to determine the starting myopia management option for now, as well as considering the future.
Myopia management starts with identifying pre-myopes and commencing the discussion with parents, so that future myopia control strategies can be successfully recommended. In our Clinical Leader Case Study format, read how Indie Grewal approached parent communication to smooth the way for eventual myopia control contact lens fitting.
Communication in myopia management can be difficult, but not always! In this confidence-building Clinical Leader Case Study, read how Lynne Fernandes approached clinical care of these two myopic brothers.
Commencing contact lens wear can be intimidating for children. In our new Clinical Leader Case Study format, read how Rachael Smith approached clinical communication to overcome reluctance to wear contact lenses.
Considering even emmetropic eyes elongate, what are the limits of myopia control efficacy? This novel analysis explores the absolute axial elongation of treated and untreated myopes in the MiSight 3-year clinical trial in comparison to previously published models of myopic and emmetropic eye growth. The results indicate a potential limit to the short-term percentage efficacy of myopia control treatments.
MiSight 1 day is a dual focus optical design. Does this affect children’s near vision? What can be done to manage any issues with near vision as noticed by wearers? Read more about expectations and adaptation.
